By ThinkSabio #ThinkSabio US Market Morning Brief
Pre-Market Gainers:
$LYRA +489% Lyra Therapeutics Reports Positive Results from the ENLIGHTEN 2 Phase 3 Trial of LYR-210 Achieving Statistically Significant Results for Primary and Key Secondary Endpoints in the Treatment of Chronic Rhinosinusitis (CRS)
$INM +197%
$VERA +77% New Drug Cuts Kidney Disease Protein by 46% in Phase 3 Trial – FDA Filing Next
Pre-Market Decliners:
$TELO – 25%Telomir Pharmaceuticals Confirms Telomir-1 Restores Vision and Retinal Structure in Age-Related Macular Degeneration (AMD) Animal Model Using FDA-Recognized Surrogate Endpoints(MAY 29)
$LOGC -18% ContextLogic Inc. to Commence Trading on the OTC Markets and Delist from Nasdaq(MAY 30)
Pre-Market Penny Gainers:
$BNAI +61%
$PSTV +46%
$AREC +17%ReElement Technologies Secures Anchor Investment from South African Firm Novare Holdings to Catalyze Rare Earth Element Refining Expansion in America’s Heartland
Headlines:
$MSFT Microsoft to invest $400 million in Switzerland on AI, cloud computing
$META Meta Aims to Fully Automate Ad Creation Using AI – WSJ